International Congress Amsterdam 2015

Saturday, 26.09.2015 Sunday, 27.09.2015 Monday, 28.09.2015 Tuesday, 29.09.2015 Wednesday, 30.09.2015		Sponsored symposia: Evening Symposium organised by Novartis Pharma AG: "IgE-mediated asthma: New revelations and future insights" Evening Symposium organised by Boehringer Ingelheim International GmbH: "The challenge of treating uncontrolled asthma on Step 3 and higher: Comparing options" Industry early morning symposium organised by Novartis Pharma AG: "Multidisciplinary approaches in the personalized care of the ALK + NSCLC patient"

Citations should be made in the following way: Authors. Title. Eur Respir J 2015; 46: Suppl. 59, abstract number.

Severe asthma phenotyping

Hot topics
Chairs: Guy Brusselle (Ghent, Belgium), Peter Sterk (Amsterdam, Netherlands)
Aims: To describe the state of the art regarding the four main severe asthma phenotypes, provide insights into the role of clinically-relevant biomarkers that relate to different phenotypes; and discuss the usefulness of biologics as add-on therapy in selected severe asthma phenotypes.
Target audience: Clinicians, clinical researchers, research fellows, and basic scientists.

Download all media

Early-onset allergic severe asthma Ratko Djukanovic (Southampton, United Kingdom)
Late-onset persistent eosinophilic severe asthma Ian Douglas Pavord (Oxford, United Kingdom)
Neutrophilic severe asthma Fabio L. M. Ricciardolo (Orbassano (Turin), Italy)